NGM Biopharmaceuticals
NGM
$1.54
Share price
0.00%
Change (1 day)
-53.89%
Change (1 year)
Categories
NGM Biopharmaceuticals (NGM) - P/B ratio
P/B ratio as of June 2024 : 0.8647
According to NGM Biopharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.8647.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
NGM Biopharmaceuticals - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4780 | -69.76% |
| 2022-12-31 | 1.58 | -61.58% |
| 2021-12-31 | 4.11 | -46.13% |
| 2020-12-31 | 7.64 | 103.97% |
| 2019-12-31 | 3.74 | |
| 2018-12-31 | N/A | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.7177 | -17.01% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 3.48 | 301.91% | 🇺🇸 USA |